共 50 条
- [41] Open-Label Single-Dose Study to Assess the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of Mirogabalin Clinical Drug Investigation, 2018, 38 : 1001 - 1009
- [42] Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open-Label, Single-Dose, Parallel Group Study JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (02): : 250 - 258
- [47] The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies Advances in Therapy, 2017, 34 : 2612 - 2624